Advertisement
Advertisement

ALXO

ALXO logo

Alx Oncology Holdings Inc

1.85
USD
+0.055
+3.07%
Dec 18, 15:59 UTC -5
Closed
...

Alx Oncology Holdings Inc Profile

About

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Info & Links

CEO

Jason Lettmann

Headquarters

323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

KPMG LLP

Share holders

81

Employees

72

Alx Oncology Holdings Inc Statistics

Valuation Measures

Market Capitalization2

97.31M

Enterprise Value

91.04M

Enterprise Value/EBITDA(ttm)

-0.55

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-93.02%

Return on Invested Capital(ttm)

-87.51%

Return on Assets(ttm)

-70.67%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-164.55M

Net Income Available to Common(ttm)

-151.16M

Diluted EPS(ttm)

-2.98

Share Statistics

Beta (5Y Monthly)

1.04

52-Week Change

-77.77%

S&P 500 52-Week Change

23.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

52.74M

Dividend Yield

0.00%

Float4

35.13M

% Held by Insiders

33.40%

% Held by Institutions

97.97%

Balance Sheet

Total Cash(mrq)

148.57M

Total Cash Per Share(mrq)

2.82

Total Debt(mrq)

9.84M

Total Debt/Equity(mrq)

7.19%

Current Ratio(mrq)

4.82%

Quick Ratio(mrq)

4.82%

Book Value Per Share(mrq)

2.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.71

Free Cash Flow(ytd)

-90.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement